Open-label, Single-arm, Multi-center, Pharmacokinetic, Safety and Tolerability Study of Levetiracetam Intravenous Infusion in Children (1 Month- 4 Years Old) With Epilepsy

Trial Profile

Open-label, Single-arm, Multi-center, Pharmacokinetic, Safety and Tolerability Study of Levetiracetam Intravenous Infusion in Children (1 Month- 4 Years Old) With Epilepsy

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jul 2015

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions
  • Sponsors UCB Pharma Inc
  • Most Recent Events

    • 24 Mar 2012 Planned number of patients changed from 18 to 22 as reported by European Clinical Trials Database record.
    • 24 Mar 2012 This trial has been completed in Belgium and Germany; and recruiting in France as reported by European Clinical Trials Database record.
    • 07 Apr 2010 Actual patient number (20) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top